We No Longer Sell This Product.





1. Cole SR, Young GP, Esterman A, Cadd A, Morcom J. A randomised trial of the impact of new faecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-122. 2. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling faecal immunochemical test for haemoglobin with a sensitive guaiac-based faecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-2159. The study was funded in part by Enterix Inc. (through Enterix Australia Pty. Ltd.), the manufacturer of InSure® FIT™. Enterix is now owned by Quest Diagnostics Incorporated. However, neither Enterix nor Quest Diagnostics participated in the data analysis or influenced the conclusions reached by the authors. 3. InSure® FIT™ Fecal Immunochemical Test Immunoassay for human hemoglobin in stool. Product Instructions. Enterix Inc., Edison, NJ. 2010. 4. InSure® FIT™ Fecal Immunochemical Test Immunoassay for human hemoglobin in stool. Patient collection instructions. Enterix Inc., Edison, NJ. 5. Hemoccult® BRAND SENSA® Patient instructions. Beckman Coulter™. October 2002. 6. Hemoccult® ICT. Patient screening kit instructions. Beckman Coulter™. June 2004.

Distributed and processed by Synergy Laboratories, INC. 4161 S. Eastern Avenue, Suite. A-6 Las Vegas NV 89119. Marketed by Markit Health, LLC, Portsmouth, NH 03801 USA. Manufactured by Enterix Inc., Edison, NJ 08837 USA, a Quest Diagnostics Company. For more information about InSure® FIT™, please visit at www.InSureTest.com. The associated logos and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. Hemoccult II® brand SENSA® elite and Hemoccult® brand ICT® are registered trademarks of Beckman Coulter. InSure® FIT™ is a trademark of Enterix Inc. and is for in vitro diagnostic use only. Markit Health™ logo is a trademark of Markit Health, LLC.